IRBESARTAN/HIDROCLOROTIAZIDA CINFA 300 mg/12,5 mg COMPRIMIDOS EFG
IRBESARTAN/HIDROCLOROTIAZIDA CINFA 300 mg/12,5 mg COMPRIMIDOS EFG
Commercialized
Register Number
72309
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
May 25, 2010
Dosage Form
COMPRIMIDO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number72309
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
HIDROCLOROTIAZIDAActive
Quantity: 12,50 mg
Name: HIDROCLOROTIAZIDA
IRBESARTANActive
Quantity: 300,00 mg
Name: IRBESARTAN
ATC CLASSIFICATION (3)
C09D
C09DA
C09DA04